| Dr Daniel Edward Van Buren, MD | |
|
100 Mcgregor St, Manchester, NH 03102-3730 | |
| (603) 669-0413 | |
| Not Available |
| Full Name | Dr Daniel Edward Van Buren |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 100 Mcgregor St, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942497615 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 14906 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Androscoggin Valley Hospital | Berlin, NH | Hospital |
| Upper Connecticut Valley Hospital | Colebrook, NH | Hospital |
| Weeks Medical Center | Lancaster, NH | Hospital |
| Memorial Hospital, The | North conway, NH | Hospital |
| Catholic Medical Center | Manchester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Androscoggin Valley Hospital Inc | 2365350725 | 43 |
| Weeks Medical Center | 2769461284 | 57 |
| Catholic Medical Center | 6103897129 | 248 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
| Entity Name | Upper Connecticut Valley Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861489437 PECOS PAC ID: 3870485923 Enrollment ID: O20040325000768 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
| Entity Name | Weeks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508819566 PECOS PAC ID: 2769461284 Enrollment ID: O20040719000284 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
| Entity Name | Catholic Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386672319 PECOS PAC ID: 6103897129 Enrollment ID: O20040813000279 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
| Entity Name | Androscoggin Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679526644 PECOS PAC ID: 2365350725 Enrollment ID: O20040929000254 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Edward Van Buren, MD 100 Mcgregor St, Manchester, NH 03102-3730 Ph: (603) 669-0413 | Dr Daniel Edward Van Buren, MD 100 Mcgregor St, Manchester, NH 03102-3730 Ph: (603) 669-0413 |
News Archive
In a study to be presented on Feb. 6 at 8:15 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in New Orleans, researchers will report findings that recommend expectant monitoring instead of immediate delivery for women with gestational hypertension or preeclampsia between 34 and 37 weeks of pregnancy.
GlobalPost's "Global Pulse" blog describes a December seminar, titled "Global Health and Story Telling in the Digital Age" and sponsored by GlobalPost and the Nieman Foundation for Journalism at Harvard, at which "journalists discussed challenges they faced in covering global health during a time of shrinking budgets and within an industry struggling to balance hard-hitting coverage with the need to continually update websites and attract readers."
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This relatively new screening test uses annual low-dose CT scans to spot lung tumors early in individuals facing the highest risks of lung cancer due to age and smoking history.
Researchers have found that a hormone responsible for controlling iron metabolism helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
› Verified 5 days ago
Jenny Lin, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Douglas F. Marks Jr., M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 87 Mcgregor St, Ste 4100, Manchester, NH 03102 Phone: 603-695-2500 Fax: 603-695-2647 | |
Dr. Jose E. Lozano, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester Va, Manchester, NH 03104 Phone: 603-624-4366 | |
Frances Jensen, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 456 Union St, Manchester, NH 03103 Phone: 866-679-0381 | |
Dr. Victor Gordan, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-626-6559 | |
Dr. Peter Wilson Shaw, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Mcgregor St # Stb, Manchester, NH 03102 Phone: 603-663-6350 | |
Dr. Goran Broketa, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-629-3217 |